Investigating the effects of prednisolone on uterine natural killer cells in women with recurrent miscarriage
Official title: Effect of Prednisolone Treatment on Uterine Natural Killer Cells and Endometrial Angiogenesis in Recurrent Miscarriage Around the Time of Embryo Implantation
Run by Chinese University of Hong Kong · NCT03902912 · Data updated 2026-11-12
This study is testing if taking prednisolone can help women who have had multiple miscarriages by looking at how it affects certain immune cells in their uterus.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 40 Years |
| Sex | Women only |
| Enrollment | 84 (estimated) |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Status | Recruiting |
| Started | July 30, 2019 |
| Main results expected | April 30, 2027 |
| Study ends | April 30, 2028 |
| Registry record updated | March 21, 2025 |
| Trial ID | NCT03902912 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women under 40 years old with a history of three or more consecutive miscarriages.
✕Probably not a fit
Patients with allergies to prednisolone or specific uterine anomalies, as well as those with certain medical conditions like antiphospholipid syndrome or diabetes, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to explore the impact of prednisolone, a glucocorticoid, on uterine natural killer (uNK) cells in women who have experienced recurrent miscarriages. Participants will receive an oral dose of 10 mg/day of prednisolone and will undergo endometrial biopsies at an outpatient clinic to assess the treatment's effects. The study seeks to clarify the inconclusive evidence surrounding prednisolone as a potential therapy for recurrent miscarriage and to understand the underlying mechanisms involved.
Why it matters
Potential benefit: If successful, this treatment could improve pregnancy outcomes for women with a history of recurrent miscarriages.
How similar studies have gone: While the evidence for prednisolone treatment in this context is inconclusive, similar studies have explored its effects, indicating a need for further investigation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Women with a history of 3 or more consecutive miscarriages 2. Women younger than 40 years old Exclusion Criteria: 1. Allergy to prednisolone 2. Women who have any uterine anomaly 3. Antiphospholipid syndrome 4. Hydrosalpinx 5. Thrombophilia 6. Abnormal thyroid function tests 7. women with diabetes,
Where it's running
-
The Chinese University of Hong Kong
Hong Kong, Hong Kong Recruiting
Study contacts
- Study coordinator: Stacey Wong, BSc
- Email: staceywong@cuhk.edu.hk
- Phone: 85235051764
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Immune cells in the uterine lining
This project will test whether the types of immune cells in blood match the immune cells in the uterine lining in women aged 18–45 with unexplained infertility, recurrent miscarriage, or other benign gynecologic reasons who are having an endometrial biopsy.
-
Exploring the Role of Antibiotics in Women with Recurrent Miscarriage and Chronic Endometritis
This study is testing if antibiotics can help women with unexplained recurrent miscarriages who also have chronic endometritis by checking for infections and seeing how well the treatment works.
-
Using prednisolone to help women with unexplained recurrent miscarriages
This study is testing if taking prednisolone can help women who have had multiple unexplained miscarriages have a successful pregnancy.
-
Immune profiling to identify biomarkers in women with repeated implantation failure or unexplained recurrent miscarriage
This study tests immune-system blood biomarkers in women with repeated implantation failure or unexplained recurrent miscarriage to see if immune imbalances can explain their pregnancy losses.
-
Mannose-binding lectin levels and repeated pregnancy or implantation failure
This project will test whether low blood levels of mannose-binding lectin are linked to repeated pregnancy loss, repeated failed embryo transfers after IVF/ICSI/FET, or other unexplained infertility in people with three consecutive pregnancy failures.
-
Exploring the link between decreased ovarian reserve and early miscarriages
This study is trying to see if having a lower number of healthy eggs is linked to early miscarriages in women, to help improve fertility treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.